Literature DB >> 7517134

Central nervous system toxicity related to FK506 in patients with Behçet's disease.

T Igarashi, Y Ishigatsubo, S Ohno, A Ueda, T Okubo, S Tanaka, Y Katsumata, T Sakane, S Ohno.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7517134      PMCID： PMC1005339          DOI： 10.1136/ard.53.5.350

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  4 in total

1.  A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis.

Authors:  M Mochizuki; K Masuda; T Sakane; G Inaba; K Ito; M Kogure; N Sugino; M Usui; Y Mizushima; S Ohno
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Mechanism of action of FK 506 and cyclosporin.

Authors:  B Steinmann; A Superti-Furga; P Bruckner
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

3.  Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus.

Authors:  T E Starzl; S A Schneck; G Mazzoni; J A Aldrete; K A Porter; G P Schröter; L J Koep; C W Putnam
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

4.  Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats.

Authors:  H Kawashima; Y Fujino; M Mochizuki
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-08       Impact factor: 4.799
  4 in total
  1 in total

1.  Behçet's Disease.

Authors:  Gulsen Akman-Demir; Sabahattin Saip; Aksel Siva
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.